Pfizer CEO: Transforming Drug Discovery, Lessons from China and Leading with Optimism
Listen to the original audio · Transcribed with NVIDIA Parakeet · Why times can differ in your player
Mm. Hi everyone and uh welcome to In Good Company. I'm uh Nikolai Tangen, uh the head of the Norwegian Sovereign Welfare, and today I'm in particular good company because I'm here with Albert Burla, who is the chairman and CEO of Pfizer, one of the largest pharma companies. In the world. Now Alberti has been with Fison for thirty years, been CEO since two thousand nineteen. and has led the company through a remarkable period of change. Warm welcome.
Thank you very much. And so you know I'm with Pfizer thirty three years. I'm with my wife. I'm with my wife thirty. I I got it mixed up there, and Now, a lot of stuff has happened since you took over as uh CEO. What what are you most excited about just now? Yeah, I think uh I'm always excited uh by by the future, like all CEOs, right? They see the the opportunities I had and um uh science is at the highest uh
levels uh we ever had it and science is affecting our business uh very big time. So I'm very, very optimistic. about the scientific progress that we can see. in the next uh years until the end of the decade. You sharpen the focus on innovative medicine, so love consumer healthcare and so on.
We already have this episode, so unlocking it is cheap and permanent: the full transcript (48 minutes, 7,914 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.
No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 5 episodes for $3.49, and monthly plans are cheaper still.